What is the current Price Target for the AlloVir Inc stock?

The average AlloVir Inc target price is $0.80. This is 0.13% higher than the current stock price. The highest price target is 25.16%, the lowest is -37.42%. 3 Analysts have issued a price target AlloVir Inc 2025 .

How high will the AlloVir Inc stock rise?

No reliable answer can be given as to how high the AlloVir Inc stock will rise. The performance of stocks, including the AlloVir Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the AlloVir Inc stock today?

The performance of AlloVir Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the AlloVir Inc stock fall?

The decline in AlloVir Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

AlloVir Inc Forecast, price target & analysts

$0.80

2.27% day before yesterday

Nasdaq, Sep 27, 10:00 pm CET

ISIN

US0198181036

Symbol

ALVR

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

AlloVir Inc Target price 2024 - Analyst rating & recommendation

AlloVir Inc Classifications & Recommendation:

Hold

33%

Sell

67%

AlloVir Inc Price Target

Target Price	$0.80
Price	$0.80
Potential	0.13% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target AlloVir Inc 2025 . The average AlloVir Inc target price is $0.80. This is 0.13% register free of charge higher than the current stock price. The highest price target is $1.00 25.16% register free of charge , the lowest is $0.50 37.42% register free of charge .
	A rating was issued by 3 analysts: 0 Analysts recommend AlloVir Inc to buy, 1 to hold and 2 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the AlloVir Inc stock has an average upside potential 2025 of 0.13% register free of charge . Most analysts recommend the AlloVir Inc stock at Sale.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-1.83	-0.42
	16.82%	77.05%
P/E		negative

1 Analysts have issued a AlloVir Inc forecast for earnings per share. The average AlloVir Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2023	$-1.83	16.82%
2024	$-0.42 77.05% Unlock
2025	$-0.32 23.81% Unlock

Current	-0.65	48.00%
2024	-1.90 192.31% Unlock
2025	-2.50 31.58% Unlock

AlloVir Inc...

Discover more stocks with a high price target

Valneva 193.41%

CureVac N.V. 166.83%

Evotec 97.18%

Plug Power Inc. 78.07%

Bavarian Nordic 35.24%

Volkswagen VZ 35.11%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now